Omada Health, Inc. (OMDA): Operating Cash Flow
$18.25M
Year ended 2025-12-31
$23.68M
Trailing 12 months to 2026-06-30
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $18.25M | n/m | 2026-03-06, From 2025-01-01 |
| 2024-12-31 | -$34.18M | n/m | 2026-03-06, From 2024-01-01 |
| 2023-12-31 | -$49.74M | n/a | 2026-03-06, From 2023-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | 2025-12-31 | $18.25M | n/m |
| DocGo Inc. (DCGO) | 2025-12-31 | $34.45M | -50.9% |
| Strata Critical Medical, Inc. (SRTA) | 2025-12-31 | -$48.91M | n/m |
| GeneDx Holdings Corp. (WGS) | 2025-12-31 | $33.28M | n/m |
| U S Physical Therapy Inc (USPH) | 2025-12-31 | $75.06M | +0.2% |
| Pennant Group, Inc. (PNTG) | 2025-12-31 | $48.29M | +22.9% |
| InnovAge Holding Corp. (INNV) | 2026-06-30 | $64.71M | +96.9% |
| LifeStance Health Group, Inc. (LFST) | 2025-12-31 | $146.15M | +36.3% |
| P3 Health Partners Inc. (PIII) | 2025-12-31 | -$91.24M | n/m |
Compare OMDA, DCGO, SRTA, WGS side by side · Screen every company in Services-Health Services ↗